FSME-IMMUN ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2010-019438-28-SE (EUCTR) | 17/05/2010 | 18/03/2010 | Vaccination against TBE in patients who use immunosuppressive drugs | Vaccination against TBE in patients who use immunosuppressive drugs | TBE vaccin in patients using immunosuppressive drugs MedDRA version: 12.1;Level: LLT;Classification code 10046859;Term: Vaccination MedDRA version: 12.1;Classification code 10037153;Term: Psoriasis MedDRA version: 12.1;Classification code 10039073;Term: Rheumatoid arthritis MedDRA version: 12.1;Classification code 10054980;Term: Immunosuppressant drug therapy | Trade Name: FSME-IMMUN Other descriptive name: TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED) | Mälarsjukhuset Eskilstuna | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Sweden |